SBC Medical Group Holdings (SBC) AI Stock Analysis

• Market Cap: $425.69M
• Dividend Yield: N/A
• Average Volume (3M): 65.67K
• Price to Earnings (P/E): 7.8
• Beta (1Y): 0.67
• Revenue Growth: 236.18%
• EPS Growth: N/A
• Country: US
• Employees: 863
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): 0.14
• Shares Outstanding: 102,576,940
• 10 Day Avg. Volume: 48,167
• 30 Day Avg. Volume: 65,672
• PEG Ratio: 2.43
• Price to Book (P/B): 1.79
• Price to Sales (P/S): 2.56
• P/FCF Ratio: 12.15
• Enterprise Value/Market Cap: 0.74
• Enterprise Value/Revenue: 1.81
• Enterprise Value/Gross Profit: 2.48
• Enterprise Value/Ebitda: 3.96
• 1Y Price Target: $8.50
• Price Target Upside: 90.16% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): 0.44
• Revenue Forecast (FY): $178.83M

• Rating: 67 Neutral
• Price Target: $5.00 ▲(11.86% Upside)
• Action: Downgraded Date: 03/28/26
• Date: Action: Downgraded 03/28/26

The score is driven primarily by solid profitability and balance-sheet strength, partially offset by 2025 revenue contraction and less consistent cash conversion. Valuation is attractive on a low P/E, while technicals remain weak-to-neutral with price below key longer-term averages. Corporate actions are broadly positive (U.S. expansion and buyback), tempered by potential dilution risk from the shelf registration.

Positive Factors

High profitability and ROE

SBC's sustained high ROE and rising net income indicate durable operating leverage in elective healthcare. Strong margins and profit conversion support reinvestment, ability to fund strategic initiatives and shareholder returns even as top-line lags, underpinning long-term financial resilience.

Negative Factors

2025 revenue contraction

A material top-line decline erodes scale benefits in clinic economics and pressures unit profitability over time. If demand softness persists, SBC may need sustained marketing spend or pricing changes to restore growth, which could compress margins and slow execution of multi-brand expansion plans.

SBC Medical Group Holdings Business Overview & Revenue Model

Company Description

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as...

Read more

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as...

How the Company Makes Money

SBC primarily makes money through fees and revenues tied to the delivery of aesthetic/elective medical services and the management/support of affiliated clinics. Key revenue streams generally include (1) patient-service revenue generated when trea...

Read more

SBC primarily makes money through fees and revenues tied to the delivery of aesthetic/elective medical services and the management/support of affiliated clinics. Key revenue streams generally include (1) patient-service revenue generated when trea...

SBC Medical Group Holdings Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	173.61M	205.42M	193.54M	174.16M
Gross Profit	127.28M	156.05M	137.30M	114.83M
EBITDA	70.17M	77.28M	85.87M	29.64M
Net Income	50.99M	46.61M	39.37M	6.32M
Balance Sheet
Total Assets	380.45M	266.08M	258.81M	225.48M
Cash, Cash Equivalents and Short-Term Investments	164.09M	125.04M	103.02M	53.64M
Total Debt	51.64M	12.21M	22.87M	16.13M
Total Liabilities	117.14M	71.06M	115.00M	117.63M
Stockholders Equity	248.28M	195.11M	142.16M	105.25M
Cash Flow
Free Cash Flow	36.55M	17.17M	39.44M	-24.99M
Operating Cash Flow	38.92M	20.58M	50.64M	-47.37K
Investing Cash Flow	-20.97M	-10.10M	1.82M	-32.65M
Financing Cash Flow	24.04M	22.97M	6.14M	-7.98M

SBC Medical Group Holdings Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 4.47
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SBC, the sentiment is Neutral. The current price of 4.47 is above the 20-day moving average (MA) of 3.98, above the 50-day MA of 4.12, and above the 200-day MA of 4.18, indicating a neutral trend. The MACD of 0.10 indicates Negative momentum. The RSI at 52.55 is Neutral, neither overbought nor oversold. The STOCH value of 47.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SBC.

SBC Medical Group Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRAI	70 Outperform	$1.05B	24.31	26.10%	0.97%	8.69%	34.58%
SBC	67 Neutral	$425.69M	7.78	21.08%	―	236.18%	―
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
FC	62 Neutral	$242.92M	-18.76	-4.11%	―	-7.02%	-86.27%
FORR	46 Neutral	$96.84M	-1.29	-80.76%	―	-8.73%	-1168.15%
RGP	45 Neutral	$124.27M	-3.31	-49.24%	6.74%	-10.83%	-1669.11%
AERT	45 Neutral	$29.17M	5.84	―	―	-3.87%	-104.63%

SBC Medical Group Holdings Corporate Events